Massive Growth is Expected for this Medical Cannabis Company | Khiron Life Sciences
Medical cannabis is gaining momentum worldwide. Khiron Life Sciences, medical cannabis company, is targeting the medical needsof Latin America’s six hundred and twenty million people. We are poised for massive growth.
About Khiron Life Sciences Corp & medical cannabis
Khiron Life Sciences Corp. is a medical cannabis company in Latin America. Our core operations are in Colombia. We have earned license in the country for the cultivation, production, domestic distribution, and international export. We have license for both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. In May 2018, Khiron listed on the TSX Venture Exchange, becoming the first Colombian based medical cannabis company to trade on any exchange globally.
With a focused regional strategy and patient oriented approach, the Company combines many different factors. These factors include global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription. It also includes brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people. Alvaro Torres, Co-founder and Chief Executive Officer, leads Khiron Life Sciences together with an experienced executive team. And a knowledgeable Board of Directors that includes former President of Mexico, Vicente Fox.
For more information on Khiron Life Sciences Corp. (KHRN:TSX.V) please fill out the form below.